<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>103</startPage>
              <endPage>107</endPage>
              <doi>10.26663/cts.2020.00022</doi>
              <publisherRecordId>119</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">The prognostic significance of the systemic immune-inflammatory index in surgically treated non-small cell lung cancers</title>
                <authors>
                              <author>
                                <name>Muhammet  Sayan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Irmak  Akarsu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>İsmail  Tombul</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Aykut  Kankoç</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Dilvin  Özkan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Elgun  Valiyev</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Celik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>İsmail Cüneyt Kurul</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Olgun Kadir Arıbaş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Abdullah İrfan Taştepe</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Gazi University School of Medicine, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Lung cancer is a leading cause of cancer-related deaths worldwide, and the majority
of lung cancer deaths are due to non-small cell cancers. The most important indicator of prognosis in
lung cancer is the tumor stage. In recent years, studies investigating the correlation between cancer
development, prognosis, and inflammation have increased. In our study, the prognostic efficacy of the
systemic immune-inflammation index (SSI) was investigated in patients with surgically treated nonsmall
cell lung cancer in pathologic stage III-A, according to the eighth edition TNM stage classification.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Following the approval of the local ethics committee, the data of patients with
stage III-A lung cancer who were operated on in our clinic between January 2010 and December 2019 were
retrospectively analyzed. In accordance with the definitions in the literature, systemic immune-inflammation
index groups were calculated using the following formula: (neutrophil count) x (platelet count) / (lymphocyte
count) in the preoperative complete blood count tests of patients; the cut-off value was determined by ROC
analysis. According to this value, high and low SSI groups were created. The survival difference between the
groups was determined by Kaplan–Meier, log-rank, and Cox regression analysis.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; A total of 181 patients were included in the study -27 women and 154 men. The median age
was 62 (age range: 25 - 82), and the median tumor diameter was 4.5 cm (0.1 - 10 cm). The cut-off value
for the SII was calculated as 1,046.105 by ROC analysis. There were 27 patients in the high SSI group
and 154 patients in low SSI group. Survival was significantly worse in the high SSI group (P = 0.02,
HR: 1.9, 95% CI). In addition, survival was significantly worse in the pneumonectomy group (P = 0.01).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Using the SSI is a simple and inexpensive way to predict prognosis in patients with stage
III-A lung cancer who are treated surgically.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=119</fullTextUrl>
              <keywords><keyword>lung cancer</keyword><keyword>prognosis</keyword><keyword>systemic immune-inflammatory index</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>108</startPage>
              <endPage>117</endPage>
              <doi>10.26663/cts.2020.00023</doi>
              <publisherRecordId>120</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Changes in neutrophil to lymphocyte ratio after non-small cell lung cancer resection: a retrospective cohort study</title>
                <authors>
                              <author>
                                <name>Armagan  Hazar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Serda Kanbur Metin</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Chest Diseases, Health of Science University Sureyyapasa Chest Diseases and Thoracic Surgery Teaching and Research Hospital, İstanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Health of Science University Sureyyapasa Chest Diseases and Thoracic Surgery Teaching and Research Hospital, İstanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Increasing neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR)
define and grade systemic inflammation in lung cancer patients. We hypothesized a decrease in NLR
and PLR after tumor resection, and their potential prognostic value in follow-up.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; Adult patients diagnosed previously (and/or histopathologically after lung
surgery) with NSCLC were enrolled from the1st January 2016 to 1st January 2018. Patients were
grouped according to tumor size (≥ 5 cm and &lt; 5 cm) and sub-grouped by gender and type of surgery
(lobectomy and pneumonectomy). Patient information was recorded from the hospital database and
included age, gender, hemogram and blood biochemistry values, results, and before and after lung
resection. Total leukocyte count, neutrophil count, NLR, PLR, PLT/MPV, and C-reactive protein (CRP)
were recorded and calculated. Mortality was recorded during the follow-up period.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Among the 314 included patients (56, 18% female, mean age 60 years, SD=11) pneumonectomy
and lobectomy numbers were 56 (18%) and 258 (82%), respectively, and 92 (29%) patients had larger
tumors and 222 (71%) had smaller tumors NLR, PLR and CRP median values immediately before and
after tumor resection were 17.08 vs. 10.03, P &lt; 0.001, 315.61 vs. 215.10, P &lt; 0.001, and 9.0 vs. 9.5, P =
0.10, respectively. Median follow-up was 300 days (IQR 198-381), and 36 (11.5%) patients died. Cox
regression showed that a post-operative NLR ≥ 12.0 was a significant prognostic indicator (HR: 2.09,
CI 95% [1.08-4.06], and P = 0.029).&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;NLR &gt;12 after lung resection may be an important prognostic value for six-month mortality.
NLR and PLR may be useful biomarkers in NSCLC immediately post-surgery and for long-term follow-up.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=120</fullTextUrl>
              <keywords><keyword>lung cancer</keyword><keyword>neutrophil</keyword><keyword>lymphocyte</keyword><keyword>biomarkers</keyword><keyword>thoracic surgery</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>118</startPage>
              <endPage>124</endPage>
              <doi>10.26663/cts.2020.00024</doi>
              <publisherRecordId>121</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Primary pulmonary carcinosarcomas: postoperative results and survival analysis</title>
                <authors>
                              <author>
                                <name>Mustafa Vedat Dogru</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celal Bugra Sezen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Cemal  Aker</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Volkan  Erdogu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Inanc  Yazıcı</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Aysun  Olcmen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muzaffer  Metin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Health of Science University, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;In this study, we assessed the long-term results of 11 patients that we operated due to
primary pulmonary carcinosarcoma in the light of literature.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We analyzed 11 patients’ data, who underwent lung resection, retrospectively
between 2009-2018. The comorbidity score was calculated according to the modified Charlson
Comorbidity Index (CCI).&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Of the 11 patients in the study, 10 (90.9%) were male, one was female (%9.1), and the median
age of the subjects was 59.18 ± 8.86. Nine of the patients (81.8%) underwent lobectomy, two of them
(18.1%) underwent pneumonectomy. As a cellular type, 6 of them have squamous cell carcinoma, 5 of
them have adenocarcinoma. Furthermore, as a sarcomatous component, we detected 6 of the patients
have spindle cell sarcoma, 3 of them have chondrosarcoma, one of them has osteosarcoma. and one
patient has angiosarcoma. Nine complications occur postoperatively in 5 patients (45.9%). The fiveyear
survival rate was 36.4%. Patients who received adjuvant chemotherapy, the five-year survival rate
was 50%, meanwhile, patients who did not receive adjuvant chemotherapy five-year survival rate was
not detected (P = 0.006). If the patients have CCI score is two and below their five-year survival rate
was 44.4%, meanwhile if the patients have CCI score is two and above their five-year survival rate was
not detected (P = 0.018). Recurrence or metastasis was diagnosed in 7 patients (63.6%) postoperatively.
The 5-year disease-free survival rate is 12.5%.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Surgical resection is still the most effective treatment modality for these patients. Adjuvant
therapy and comorbidity are detected most important factors that affect the survival rate.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=121</fullTextUrl>
              <keywords><keyword>carcinosarcoma</keyword><keyword>survival</keyword><keyword>surgery</keyword><keyword>lung</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>125</startPage>
              <endPage>130</endPage>
              <doi>10.26663/cts.2020.00025</doi>
              <publisherRecordId>122</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">The relationship of platelet lymphocyte ratio with prognosis in patients with chronic obstructive pulmonary disease</title>
                <authors>
                              <author>
                                <name>Mehmet Reşit Öncü</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ufuk  Çobanoğlu</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Emergency Medicine, Van Yüzüncü Yıl University, Faculty of Medicine, Van, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Van Yüzüncü Yıl University, Faculty of Medicine, Van, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; The aim of this study is to analyze prognostic biomarkers, and determine the biomarkers
which are more sensitive in the patients that were presented with acute chronic obstructive pulmonary
disease (COPD) exacerbation to the emergency department.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; The data of 243 patients presented with acute COPD exacerbation and 122
COPD patients with stable status as control group were analyzed retrospectively. The patients, whose
arterial blood gas (ABG) studied, with Acute COPD exacerbation were identified as Group I. The
patients whose venous blood gas (VBG) studied were identified as Group II and stable COPD patients
whose ABG studied were identified as Control Group. The prognostic biomarker values were compared
in the patients of Group I, Group II and Control Group.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The mean age of the patients was 68.61 ± 11.02 and the mean age of the control group was
68.25 ± 11.07. It was found that platelet lymphocyte ratio (PLR) values were very high in both Group I
and Group II compared to the control Group (P &lt; 0.001). There was a significant difference related with
mean erythrocyte distribution width (RDW) in Group I, mean erythrocyte volume (MCV)’ in group II,
MPV and platelet count (PLT) in both Group I and Group II (P &lt; 0.001).&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Especially in acute COPD exacerbation, PLR may be a useful inflammatory biomarker to
reflect the severity and activity of inflammation in COPD patients.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=122</fullTextUrl>
              <keywords><keyword>chronic obstructive pulmonary disease</keyword><keyword>biomarker</keyword><keyword>platelet-lymphocyte ratio</keyword><keyword>emergency department</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>131</startPage>
              <endPage>136</endPage>
              <doi>10.26663/cts.2020.00026</doi>
              <publisherRecordId>123</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Rare and unusual tracheobronchial foreign bodies</title>
                <authors>
                              <author>
                                <name>Huseyin  Yildiran</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Guven Sadi Sunam</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Selcuk University Medical Faculty, Thoracic Surgery, Konya, Turkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Foreign body aspirations are rare in adults but are common in children between the ages of
0-3. Clinically, cough is the most common complaint. Delays in diagnosis can cause complications in the
lower respiratory tract and lung parenchyma. This study aimed to offer a reminder that rare and unusual
foreign bodies may be the cause of tracheobronchial aspiration and to present the surgical approach.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Patients who were admitted to our outpatient clinic or who were referred by
other clinics for foreign body aspiration between January 2012 and January 2017 were retrospectively
analyzed. Foreign objects such as coins, food pieces, toy pieces, and needles, which were routinely
encountered, were excluded from the study. Gender, age, complaints, radiological findings, and surgical
interventions were recorded.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; There were five cases (four males, one female) under the age of 18 and three male cases above
the age of 18. The average age was 21.18 ± 28.93. There was one case with laryngectomy. In six cases,
the foreign body was removed by rigid bronchoscopy. Lung resection was performed in three cases (one
lobectomy and one wedge resection). The foreign bodies were a pen tip, a piece of stone, a rivet from jeans,
the LED of a remote control, a latch spring, a piece of a spoon, a wood piece, and a piece of a dental filling.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Foreign body aspirations are among the most significant causes of morbidity and mortality,
especially in the child age group. Diagnosis is possible through anamnesis, physical examination, and
evaluation of radiological findings together. In the event of clinical suspicion, foreign body aspirations
should be kept in mind regardless of age group.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=123</fullTextUrl>
              <keywords><keyword>airway management</keyword><keyword>bronchoscopic surgical procedure</keyword><keyword>respiratory aspiration</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>137</startPage>
              <endPage>141</endPage>
              <doi>10.26663/cts.2020.00027</doi>
              <publisherRecordId>124</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Atypical uniportal thoracoscopic resection of a giant thymolipoma</title>
                <authors>
                              <author>
                                <name>Hakkı  Ulutaş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muhammet Reha Çelik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayşenur  Akatlı</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet  Ağar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>İlham  Gülçek</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Emine  Şamdancı</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Erdal  İn</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Faculty of Medicine, University of Inonu, Malatya, Turkey</affiliationName><affiliationName affiliationId="2">Department of Pathology, Faculty of Medicine, University of Inonu, Malatya, Turkey</affiliationName><affiliationName affiliationId="3">Department of Pulmonology, Faculty of Medicine, University of Fırat, Elazıg, Turkey</affiliationName></affiliationsList><abstract language="eng">Thymolipoma is a rare, slow-growing, benign anterior mediastinal tumor consisting of mature adipose
tissue and thymic tissue. Herein we describe the case of a completely excised giant thymolipoma with
uniportal video-assisted thoracoscopic surgery, which was detected incidentally on chest X-ray, with the
review of the literature. A 30-year-old male patient was hospitalized to the department of general surgery
with the diagnosis of appendicitis. Preoperative chest x-ray revealed mediastinal enlargement extending
to the diaphragm at right paracardiac area where cardiac contours were erased and cardiomegaly-like
appearance was observed. In the contrast-enhanced computed tomography of the chest, a massive mass
of soft tissue was detected in fat density. The mediastinal lesion was completely excised with uniportal
VATS. Histopathologically, the tumor was reported to be thymolipoma. Thymolipoma it should be
totally removed with VATS surgery for both diagnosis and treatment.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=124</fullTextUrl>
              <keywords><keyword>thymolipoma</keyword><keyword>uniportal VATS</keyword><keyword>mediastinal mass</keyword><keyword>giant</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>142</startPage>
              <endPage>145</endPage>
              <doi>10.26663/cts.2020.00028</doi>
              <publisherRecordId>125</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A mass-forming extramedullary hematopoiesis case mimicking mediastinal neoplasia</title>
                <authors>
                              <author>
                                <name>Ramazan  Uçak</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Özlem Ton Eryılmaz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Uğur  Temel</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Fevziye  Kabukcuoğlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Pathology, University of Health Sciences, Şişli Hamidiye Etfal Health Application and Research Center, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, University of Health Sciences, Şişli Hamidiye Etfal Health Application and Research Center, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Extramedullary hematopoiesis (EMH) is a condition that usually coexists with hematological disorders
and rarely causes mass formation. It can occur anywhere in the body, but very rarely becomes a tumorlike
mass in the posterior mediastinum and paravertebral region. A 41-year-old female patient presented
with respiratory distress. Radiologically, multiple large mass lesions were detected in the posterior
mediastinum, localized bilaterally at paravertebral regions. Diagnostic studies with transthoracic
biopsy specimen were showed that the mass lesion was consisting of myelocytes, lymphocytes,
erythrocytes and megakaryocytes, so the case was reported as EMH. The case was presented to make a
differential diagnosis, because it mimics solid neoplasms at unusual localizations, and may accompany
hematological disorders.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=125</fullTextUrl>
              <keywords><keyword>extramedullary hematopoiesis</keyword><keyword>solid mass</keyword><keyword>posterior mediastinum</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>146</startPage>
              <endPage>148</endPage>
              <doi>10.26663/cts.2020.00029</doi>
              <publisherRecordId>126</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">A rare presentation of a rare disease: endobronchial hamartoma with lobar bronchiectasis</title>
                <authors>
                              <author>
                                <name>Ömer  Yavuz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Murat  Kapdağlı</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Suat  Erus</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Pınar  Bulutay</name>
                                <affiliationId>4</affiliationId>
                              </author>
                              <author>
                                <name>Serhan  Tanju</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of General Thoracic Surgery, Koç University Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="2">Department of General Thoracic Surgery, VKF American Hospital, Istanbul, Turkey</affiliationName><affiliationName affiliationId="3">Department of General Thoracic Surgery, Koç University School of Medicine, Istanbul, Turkey</affiliationName><affiliationName affiliationId="4">Department of Pathology, Koç University Hospital, Istanbul, Turkey</affiliationName></affiliationsList><abstract language="eng">Benign lung tumors are very rare, endobronchial hamartomas -one of which- are even more rare.
Endobronchial masses tend to represent themselves via obstruction related symptoms and endobronchial
hamartomas are not an exception. It is important to diagnose endobronchial masses before they bring
untreatable damage to the lung. It is also important to differentiate endobronchial hamartomas from
endobronchial malignancies, such as carcinomas, for they also tend to act mildly symptomatic for a long
period of time. In our case, the patient was admitted to our clinic with the symptoms of cough and mild
hemoptysis. A computed chest tomography showed total bronchiectasis of right upper lobe along with
an endobronchial mass in the right upper lobe bronchus. Bronchoscopic biopsy of the mass revealed
no diagnosis. We performed a right upper lobectomy and the pathological examination resulted as
endobronchial hamartoma. There are numerous cases about endobronchial hamartomas in the literature
which represented with countless symptoms and diseases as persistent cough, recurrent pneumonia, local
bronchiectasis and so forth. Our case of endobronchial hamartoma representing with total bronchiectasis
of a whole lobe of the lung is the first and only case in the English literature to our knowledge.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=126</fullTextUrl>
              <keywords><keyword>endobronchial hamartoma</keyword><keyword>endobronchial mass</keyword><keyword>bronchiectasis</keyword><keyword>videothoracoscopic surgery</keyword><keyword>lobectomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>2020-06-27</publicationDate>
              <volume>5</volume>
              <issue>3</issue>
              <startPage>149</startPage>
              <endPage>152</endPage>
              <doi>10.26663/cts.2020.00030</doi>
              <publisherRecordId>127</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Cryosurgery of endobronchial tuberculosis facilitated by foley’s catheter usage for both intubation and distal airway safety</title>
                <authors>
                              <author>
                                <name>Şevki Mustafa Demiröz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gülşen  Yılmaz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Göktürk  Fındık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey</affiliationName></affiliationsList><abstract language="eng">A 35-year-old female with a reproductive cough, dyspnea, stridor, and intermittent hemoptysis was
evaluated by fiberoptic bronchoscopy (FOB). An endobronchial lesion was observed 2 cm distal to the
vocal cords, occluding two-thirds of the tracheal lumen. Rigid bronchoscopy and total excision of the
lesion with cryosurgery were planned. Under general anesthesia, a 14-mm rigid bronchoscope (RB)
was introduced. As a facilitative new technique, the patient was intubated with an 18F Foley catheter,
which was introduced close to the RB. The cuff of the catheter was then inflated distally to the lesion.
Subsequently, the catheter was connected to a mechanical ventilator to ensure the safety of the airway
while preventing hypoxia. Total excision of the mass was performed via cryosurgery. Immediately after,
the catheter balloon was deflated, and a fiberoptic bronchoscope was introduced through the RB to
explore the distal bronchial system for aspirated tissue fragments and secretions. With this facilitative
approach, the distal airway was kept clean of secretions and tissue fragments. The final pathology of
the mass was granulomatous inflammation and necrosis, and the patient was referred to a tuberculosis
clinic for medical treatment.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=127</fullTextUrl>
              <keywords><keyword>dyspnea</keyword><keyword>endobronchial tuberculosis</keyword><keyword>endobrochial treatment</keyword><keyword>cryosurgery</keyword>
                  </keywords>
            </record></records>